Erian et al.
1041
1
1630 cm–1 (CϭC). H NMR (DMSO), δ: 7.20–7.82 (m, 4H,
Ar-H), 8.00 (s, 1H, H-11), and 8.50 ppm (br, 2H, NH2).
Anal. calcd. for C15H7NO5 (281): C 64.0, H 2.4, N 4.9;
found: C 63.9, H 2.3, N 4.7. Mass, m/z: 281 (M+).
moiety). Anal. calcd. for C20H17N3O6S (427): C 56.2, H 3.9,
N 9.8, S 7.4; found: C 56.0, H 3.6, N 9.5, S 7.1. Mass, m/z:
427 (M+).
1-Benzyl-5-[7-methyl-3,4-dihydro-7-methyl-3-(p-tolyl)-4-
oxo-thieno[3,4-d]pyridazin-1-carboxylate]-3-ylthiourea
(13)
Dimethyl 4-aminobenzo[c]coumarin-2,3-dicarboxylate (8)
A mixture of 1 (2.17 g, 0.01 mol) and dimethyl fumarate
(1.44 g, 0.01 mol) was heated in an oil bath at 170°C for
4 h. The reaction mixture was cooled, then triturated with
ethanol. The solid product, so formed, was collected by fil-
tration and crystallized from dioxane as brown needles,
(2.5 g, 76%), mp > 300°C. IR, ν (KBr): 3464–3351 (NH2),
3095 (CH aromatic), and 1721–1608 cm–1 (3 CϭO). 1H
NMR (300 MHz, CDCl3), δ: 3.68 (3 H, s, CO2Me), 3.74
(3H, s, CO2Me), 6.69–7.06 (1H, dd, J = 8.19 and 1.15, 7-H),
7.02 (1H, s, 1-H), 7.05–7.15 (1H, ddd, J = 7.91, 7.69, and
1.18, 9-H), 7.27–7.36 (1H, ddd, J = 8.16, 7.75, and 1.47, 8-
H), 7.74–7.78 (1H, dd, J = 8.11 and 1.41, 10-H), 9.05 (2H,
br s, NH2). Anal. calcd. for C17H13NO6 (327): C 62.3, H 3.9,
N 4.2; found: C 62.2, H 3.8, N 4.1. Mass, m/z: 327 (M+).
To a suspension of ammonium thiocyanate (0.76 g, 0.01
mol) in dry acetone (20 mL), benzoyl chloride (1.4 g, 0.01
mol) was added. The reaction mixture was refluxed for
5 min then treated with 2 (3.2 g, 0.01 mol). The reaction
mixture was refluxed for 3 h, then left to cool. The resulting
solution was poured onto ice water. The solid product, so
formed, was collected by filtration and crystallized from
dioxane as yellow needles (4.8 g, 97%), mp 270°C. IR, ν
(KBr): 3350–3220 (2 NH), 2948 (CH3), 1732 (ester CO),
1
1675 (2 CϭO), and 1641 cm–1 (CϭC). H NMR (DMSO),
δ: 2.40 (s, 3H, CH3), 3.30 (s, 3H, CH3), 3.98 (s, 3H, OCH3),
7.3–7.7 (m, 9H, Ar-H), 12.10 (br, 1H, NH), and 15.20 ppm
(br, 1H, NH). 13C NMR, δ: 177.08 (CϭO), 174.32 (CϭO),
169.26 (CϭS), 165.71 (ring CϭO), 159.12 (C-1), 147.95
(C-5), 139.31–125.65 (phenyl ring), 121.96 (C-7), 117.38
(C-7a), 106.42 (C-4a), 54.65 (CH3), 22.26 (CH3), 14.92
(CH3). Anal. calcd. for C24H20N4S2O4(492): C 58.5, H 4.0,
N 11.3, S 13.0; found: C 58.2, H 3.9, N 11.1, S 12.6. Mass,
m/z: 492(M+).
Methyl 6-amino-8,8a-dihydro-2,5-dioxo-8a-methyl-4-(p-
tolyl)-1,3,4-thiadiazaacenaphthene-7-carboxylate (11)
A solution of 2 (3.2 g, 0.01 mol) in dioxane (20 mL) and
few drops of acetic acid was treated with methyl acrylate
(0.86 g, 0.01 mol). The reaction mixture was refluxed for
10 h, then evaporated in vacuo. The remaining product was
triturated with water, and the resulting solid product was
collected by filtration and crystallized from dioxane as red
needles (3 g, 79%), mp 201°C. IR, ν (KBr): 3402–3292
(NH2), 2987 (CH3), 1711 (CϭO), 1676 (ring CO), 1675
1. A.G. Gilman and L.S. Goodman. The pharmaceutical basis of
therapeutics. Macmillan, New York. 1985. p. 1109.
2. J.M. Domagala and P. Peterson. J. Heterocycl. Chem. 26, 1147
(1989), and refs. cited therein.
3 W.F. von Oettingen. The therapeutic agents of the quinoline
group. Chemical Catalog Co., New York. 1933.
4. R.B. Woodward and W.E. Doering. J. Am. Chem. Soc. 67, 860
(1945).
5. E. Hahn. In Lectures in heterocyclic chemistry IX. Edited by
R.N. Castle. 1990. p. 13.
6. F. Fanger, S. Nicklen, and A.R. Coulson. Proc. Natl. Acad.
Sci. U.S.A. 74, 5463 (1977).
1
(CO), and 1620 cm–1 (CϭC). H NMR (300 MHz, DMSO),
δ: 1.82 (s, 3H, CH3), 2.40 (s, 3H, CH3), 2.95 and 3.16 (AB
system, 2H, CH2, JAB = 15.7 Hz), 3.70 (s, 3H, OCH3),
7.31–7.68 (m, 4H, aromatic protons), and 8.10 ppm (br, 2H,
NH2); 13C NMR, δ: 194.20 (C-2), 171.35 (CϭO ester),
163.29 (C-5), 153.07 (C-2a), 146.01 (C-6), 144.22, 133.11,
131.20, 129.42 (aromatic ring), 124.35 (C-5a), 104.0 (C-7),
80.56 (C-8a), 50.91 (C-8), 54.82 (CH3), 15.48 (CH3). Anal.
calcd. for C19H17N3O4S (383): C 59.5, H 4.4, N 10.9, S 8.3;
found: C 59.3, H 4.2, N 10.8, S 8.2. Mass, m/z: 383 (M+).
7. M.H. Elnagdi, M.R.H. Elmoghayar, and G.E.H. Elgemeie.
Chemistry of pyrazolopyrimidines. In Advances in
heterocyclic chemistry. Vol. 41. Edited by A.R. Katritzky. Aca-
demic Press, New York. 1987. p. 319.
8. M.H. Elnagdi, N.S. Ibrahim, F.M. Abdelrazek, and A.W.
Erian. Liebigs Ann. Chem. 909 (1988).
9. M.H. Elnagdi and K.U. Sadek. Synthesis, 483 (1988).
10. R. Gaertner and R.G. Tonkyn. J. Am. Chem. Soc. 73, 5872
(1951).
11. D.B. Clapp. J. Am. Chem. Soc. 61, 2733 (1939).
12. H. Kotsuki, S. Kitagawa, H. Nishizawa, and T. Tokoroyama. J.
Org. Chem. 43, 1471 (1978).
13. J.M. Barker, P.R. Huddleston, and S.W. Shutler. J. Chem. Soc.
Perkin Trans. 1, 2483 (1975).
Methyl 6-amino-8,8a-dihydro-2,5-dioxo-8a-methyl-4-(p-
tolyl)-1,3,4-thiadiazaacenaphthene-7-carboxy-8-
carboxylate (12)
A solution of 2 (3.2 g, 0.01 mol) in a mixture of acetic
acid (10 mL) and dioxane (10 mL) was treated with maleic
anhydride (0.98 g, 0.01 mol). The reaction mixture was
refluxed for 10 h. The reaction mixture was evaporated, then
washed with ethanol. The solid product, so formed, was col-
lected by filtration and crystallized from ethanol–dioxane as
orange needles (3 g, 71%), mp 280°C. IR, ν (KBr): 3446–
3251 (NH2), 3035 (CH aromatic), 2953 (CH3), 1830–1731–
14. J.P. Chupp. J. Heterocycl. Chem. 7, 285 (1970).
15. M.H. Elnagdi, A.M. Negm, and K.U. Sadek. Synlett, 27
(1994).
1
1673 (4 CϭO), and 1637 cm–1 (CϭC). H NMR (DMSO),
16. M.H. Elnagdi, R.M. Mohareb, F.A. Abdel Aal, and H.A.
Mohamed. Phosphorus and sulfur. 82, 195 (1993).
17. E. Nyiondi-Bonguen, F.E. Sopbue, F.Z. Tanee, and D. Dopp. J.
Chem. Soc. Perkin Trans. 1, 2191 (1994).
δ: 2.40 (s, 3H, CH3), 2.79 (s, 3H, CH3), 3.40 (s, 3H, OCH3),
3.98 (s, 1H, C-8), 7.3–7.7 (m, 4H, Ar-H), 8.88 (br, protons
of NH2), and 11.70 ppm (s, 1H, COOH) (the downfield shift
of the amino group due to the effect of the amino acid
© 1998 NRC Canada